EGFR Mutations in mNSCLC: 1L TKI Inhibitors, Molecular Resistance Mechanism and Implication for Next Line Therapy, Role of ctDNA, EGFRi Efficacy
By
Lung Cancer Europe (LuCE)
FEATURING
Rolf A. Stahel
By
Lung Cancer Europe (LuCE)
FEATURING
Rolf A. Stahel
Login to view comments.
Click here to Login
Videos